Description

This application is proposed as a simple but effective aid totheindication for antithrombotic therapy in non-valvularatrialfibrillation, based on ESC guidelines.
In just ONE SCREEN, essential parameters are entered anddisplayedthe results: the scores of thromboembolic risk(CHADSVASC),haemorrhagic risk (HASBLED) and glomerular filtrationrate(Cockcroft-Gault formula). Finally, always in the same screen,areshown the resulting antithrombotic therapies, in adherence totheESC guidelines.

At the bottom of the screen data are entered:
- gendre
- age, weight (kg) and serum creatinine (mg/dL) , with keys (+)and(-) sensible to short or long click, for a quick and easyinsertionof the values
- check-list of 12 clinical-anamnestic items.

Based on the data entered, the calculated resultsareautomatically displayed in the upper section of thescreen:
At the top right are shown the scores CHADSVASC, HASBLEDandcreatinine clearance calculated by theCockcroft-Gaultformula.
In the upper left shows the resulting therapeutic indicationsbasedon ESC guidelines 2012: three "traffic lights" appearing greenorred for the three treatment options:
1) no antithrombotic therapy (NONE)
2) vitamin K antagonists (VKA)
3) New Oral Anticoagulants (NOAC).

For Italy we suggest our specific application, "AFGlobalCalculator (ItalY), based also on AIFA (Agenzia ItalianadelFarmaco) restriction for Dabigatran's prescription.

DISCLAIMER : The author assumes no responsibility for use ofthisapplication and invites who use it to verify the resultsprovidedand adapt them to the clinical context.

The "AF Global Calculator (Europe)", on the Android platform,wasdeveloped entirely (drafting of the algorithm,technicaldevelopment, graphics solutions) by Dr. FrancescoGemelli,Cardiologist in Rome.
We welcome any comments or suggestions that can be sent tothefollowing address: [email protected]

KEY-WORDS: Medical Calculator, Cardiology, ESC,guidelinesEuropean Society of Cardiology, Atrial Fibrillation,anticoagulant,antithrombotic, embolic risk, stroke risk, HASBLED,CHADSVASC,CHA2DS2-VASC, Dabigatran, Rvaroxaban, Epixaban